Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Clinical trial NCT00332436 · COMPLETED

Trial details

NCT number: NCT00332436
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Hypertension

Start date: 1999-12-01
Primary completion: 2001-11-01
Enrollment: 586

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.